Delivery Order SPE2DB20D3103-SPE2DB23FM0A6
Award Date 12/23/22
Potential Completion Date 12/27/22
Potential Value $4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,007.78 firm fixed-price delivery order is for the supply of 4,560,136,422 units of Tobramycin 300 mg/5 ml ampules, with a completion date of March 6, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,924.70 delivery order is for the supply of 4,558,009,351 units of Tobramycin 300 mg/4 ml ampules. The contract has a firm fixed price and an ultimate completion date of August 8, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,157.19 firm fixed price delivery order is for the supply of Tobramycin Pak 300 mg/5 ml, 5 ml. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $2,997.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tobramycin 300 mg/5 ml ampules, with a completion date of December 2, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $4,119.26 firm fixed price contract is for the supply of 4,558,749,565 units of the drug Tobramycin 300 mg/5 ml ampules. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $28,502.07 to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The order is for the supply of 4,564,261,702 units of the medication Tobramycin 300 mg/4 ml ampules. The delivery order has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp, as a prime contractor, also holds an indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 through...
- This is a delivery order issued under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for 4,565,218 units of Tobramycin 300 mg/5 ml ampules, a specialty medication, at a firm fixed price of $1,258.06. The contract has a period of performance through July 23, 2024 and does not have any set-aside designation, indicating open competition....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The order is for 4,559,444,890 units of TOBRAMYCIN 300 MG/5 ML AMPULE, a pharmaceutical product, at a firm fixed price of $1,092.35. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,604.14 to AmerisourceBergen Drug Corp for the supply of Tobramycin 300 mg/4 mL ampules on November 13, 2025, with completion expected by November 14, 2025. This delivery order, issued under a firm fixed-price arrangement with no set-aside designation, represents a competitively awarded transaction supporting federal pharmaceutical procurement needs. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,061.26 to AmerisourceBergen Drug Corp for Tobramycin 1.2 GM vials, a critical antibiotic pharmaceutical product. This contract was competitively awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and utilizes firm fixed pricing with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a...